3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Weight Loss
1
Preleukemia
1
Ovarian Neoplasms
1
Obesity
1
Myelodysplastic Syndromes
1
Malnutrition
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Carcinoma, Merkel Cell
1
Interventions
Melphalan
4
fludarabine
3
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Cyclophosphamide
2
Busulfan
2
Alemtuzumab
2
venetoclax
1
spartalizumab
1
sabatolimab
1
ruxolitinib
1
lintuzumab
1
filanesib
1
Stem Cell Transplantation
1
Sertraline
1
Sampling Studies
1
Metformin
1
Lenalidomide
1
Decitabine
1
Clofarabine
1
CPI-0610
1
Bone Marrow Transplantation
1
Biopsy
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Preleukemia
×
Sampling Studies
×
Clear all
NCT02809222
2021-04-19
PLASMYC
University Hospital, Tours
Phase NA
Completed
138 enrolled